Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of bcl-2 in sporadic breast carcinoma.

Cancer - 1 Dec 1997

Dueñas-González A, Abad-Hernández M M, Cruz-Hernández J J, González-Sarmiento R

Abstract excerpt

BACKGROUND: The bcl-2 gene encodes a protein that blocks apoptosis and might help to promote tumor development. It is expressed in a high percentage of breast tumors and is associated with good prognostic features. However, the mechanisms that regulate bcl-2 expression in breast carcinoma are unknown. Moreover, immunohistochemical detection of bcl-2 is related inversely to p53 expression. This notwithstanding,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blotting, Southern
Share to Breast Neoplasms
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Mutation

Share to Polymerase Chain Reaction

Share to Polymorphism, Single-Stranded Conformational

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9392332
DOI: 10.1002/(sici)1097-0142(19971201)80:11<2100::aid-cncr9>3.0.co;2-#

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of bcl-2 in sporadic breast carcinoma.PMID 9392332Read ↗

Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.Semantic proximity Read ↗

Regulators of apoptosis in human breast cancer.Semantic proximity Read ↗

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.Semantic proximity Read ↗

The bcl-2 gene status of human head and neck cancer cell lines.Semantic proximity Read ↗

BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism.Semantic proximity Read ↗

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group.Semantic proximity Read ↗

Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.Semantic proximity Read ↗

BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.Semantic proximity Read ↗

Bcl10 is not a target for frequent mutation in human carcinomas.Semantic proximity Read ↗

The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia.Semantic proximity Read ↗

Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.Semantic proximity Read ↗

Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.